Filter
3940
Filtered Results: 3940
Text search:
drug
distribution
Featured
Recommendations
320
New Publications
1161
Language
Document type
No document type
2502
Studies & Reports
602
Guidelines
454
Manuals
147
Strategic & Response Plan
120
Fact sheets
41
Training Material
39
Situation Updates
22
Infographics
8
Brochures
2
Resource Platforms
2
Online Courses
1
Countries / Regions
India
212
Kenya
127
Global
119
Uganda
106
Ethiopia
101
Nigeria
96
South Africa
82
Sierra Leone
76
Liberia
76
Nepal
73
Western and Central Europe
73
Malawi
71
Tanzania
67
Zambia
61
Myanmar / Burma
60
Ghana
58
Latin America and the Carribbean
58
Bangladesh
55
Rwanda
54
Africa
50
Ukraine
43
Namibia
42
Eastern Europe
37
Zimbabwe
36
Philippines
35
Cambodia
31
Lesotho
30
South–East Asia Region
27
Asia
26
Senegal
25
Botswana
23
Congo, Democratic Republic of
20
Indonesia
20
Russia
20
Burkina Faso
19
Mozambique
19
Colombia
16
East and Southern Africa
16
Syria
15
Haiti
14
Eswatini/ Swaziland
13
Venezuela
12
USA
11
South Sudan
11
West and Central Africa
11
Paraguay
11
Albania
11
Cameroon
10
Thailand
10
Middle East and North Africa
10
Benin
9
Brazil
9
Guinea
8
Pakistan
8
Germany
8
Peru
8
Eastern Europe and Central Asia
8
Tajikistan
8
Sudan
7
Argentina
7
Georgia
7
Moldova
6
Vietnam
6
Iraq
5
Afghanistan
5
North Macedonia
5
Bolivia
5
Laos
5
China
4
El Salvador
4
Sri Lanka
4
Chile
4
Armenia
4
Spain
4
Morocco
3
Jordan
3
Lebanon
3
Turkey
3
Papua New Guinea
3
Western Pacific Region
3
Bhutan
3
Timor Leste/ East Timor
3
Central African Republic
2
Honduras
2
Libya
2
Madagascar
2
Mexico
2
Yemen
2
Fiji
2
Mongolia
2
Southern Africa
2
Iran
2
Uzbekistan
2
Kyrgyzstan
2
North America
2
Gabon
2
Uruguay
2
Tunisia
2
United Kingdom
2
Portugal
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Somalia
1
Egypt
1
Chad
1
Ireland
1
Serbia
1
Hungary
1
Ecuador
1
Greece
1
Angola
1
Guatemala
1
Nicaragua
1
Palestine
1
North Korea
1
Canada
1
Bulgaria
1
Estonia
1
Romania
1
Kazakhstan
1
Turkmenistan
1
Jamaica
1
France
1
Maldives
1
Mauritius
1
Norway
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
1656
Clinical Guidelines
341
Public Health
205
Women & Child Health
141
Key Resources
77
Pharmacy & Technologies
57
Capacity Building
48
Annual Report MEDBOX
1
Toolboxes
HIV
433
Mental Health
345
TB
317
AMR
189
COVID-19
156
NTDs
156
Pharmacy
146
Rapid Response
69
Caregiver
62
Planetary Health
60
NCDs
58
Ebola
49
Refugee
48
Disability
45
Conflict
44
Global Health Education
41
Health Financing Toolbox
26
Natural Hazards
20
Polio
15
Specific Hazards
15
Cholera
14
Zika
14
Social Ethics
7
Health Financing
1
This report makes clear that there is a path to end AIDS. Taking that path will help ensure preparedness to address other pandemic challenges, and advance progress across the Sustainable Development Goals. The data and real-world examples in the report make it very clear what that path is. It is not...
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog...
WHO/Europe has launched a new guide, providing support to countries on how to apply behavioural and cultural insights (BCI) for health. It presents a simple step-wise approach, complemented by a rich collection of detailed considerations, tools and exercises. The guide is the first of its kind, spec...
Financing Global Health 2013: Transition in an Age of Austerity, IHME’s fifth annual report on global health expenditure, depicts financing trends that underline the resilience of development assistance for health. This year’s updated estimates show that despite lackluster economic growth and fi...
Financing Global Health 2015 is the seventh edition of IHME’s annual series on global health financing. This report captures trends in development assistance for health (DAH) and government health expenditure as source (GHE-S) in low- and middle-income countries. Annually updated GHE-S and DAH est...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. ...
This report compiles data for the first time on the far-reaching consequences of uncontrolled hypertension, including heart attacks, strokes and premature death, along with substantial economic losses for communities and countries. It also contains information on the global, regional and country-lev...
The key actions, activities, and approaches in this document are organized within each of the 5Cs (see Table 1 in the PDF) and those of the Strategic preparedness and response plan (SPRP) pillars as follows:
National action plan key activities, prioritized for the current context and the current ...
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
Prompt, effective antimalarial treatment, and supportive care can substantially reduce the rate of mortality from severe malaria. However, many children in malaria-endemic countries do not have access to health facilities or a qualified health care provider and do not receive the necessary care in a...
This checklist is an operational tool to help national authorities develop or revise national respiratory pathogen (inclusive of influenza and coronaviruses) pandemic preparedness plans.
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
Unpreparedness of health professionals to address non-communicable diseases (NCD) at peripheral health facilities is a critical health system challenge in Mozambique. To address this weakness and decentralize NCD care, training of the primary care workforce is needed. We describe our experience in t...
As the Group of Eight (G8) world leaders meet in Saint Petersburg, Russia for this year’s G8 Summit, it is important to take stock of international efforts to finance the response to the global HIV/AIDS epidemic. Financing a sufficient and sustained response to the epidemic has emerged as one of t...
In 2014, the World Heart Federation (WHF) launched
an initiative to develop a series of Roadmaps [1e6]. Their
aim is to identify potential roadblocks on the pathway to
effective prevention, detection, and management of cardiovascular disease (CVD), along with evidence-based
solutions to overcome...
This technical report has been developed within the framework of the WHO Global Initiative for
Childhood Cancer. Its goal is to improve the situation of children and adolescents with cancer worldwide,
giving them the best chances of survival, living a full life and, above all, enjoying quality of ...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
Many low- and middle-income countries (LMICs) are undergoing an epidemiological transition. With an improvement in socioeconomic conditions and an aging population, cardiovascular diseases (CVDs), like cardiac arrhythmias, are expected to increase in these countries. However, there are limited studi...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
